COMPETENCE Trial: The EVAHEART 2 continuous flow left ventricular assist device
Steven R. Allen(Penn State Milton S. Hershey Medical Center), Robert D. Dowling(Jewish Hospital), Claudius Mahr(Medical City Dallas Hospital), Jason W. Smith(University of California, San Francisco), Carlo Bartoli, Ravi Dhingra(University of Wisconsin–Madison), Dan M. Meyer(Baylor University Medical Center), Mustafa M. Ahmed(McMaster University), Ashwin Ravichandran(Saint Vincent's Catholic Medical Center), Sanjeev Gulati(Fortis Hospital), Tadashi Motomura, Masahiro Ono(Methodist Healthcare), Michael S. Kiernan(Tufts Medical Center), Gregory F. Egnaczyk(Christ Hospital), Yoshiya Toyoda(Philadelphia University), Behzad Soleimani(Penn State Milton S. Hershey Medical Center), Mark S. Slaughter(University of Louisville), Alexis E. Shafii(University of Kentucky), Leora T. Yarboro(University of Virginia)
Cited by 29
Related Papers
Clinical management of continuous-flow left ventricular assist devices in advanced heart failure
|The Journal of Heart and Lung Transplantation|2010|876
Intrapericardial Left Ventricular Assist Device for Advanced Heart Failure
|New England Journal of Medicine|2017|757
Left Atrial Appendage Occlusion during Cardiac Surgery to Prevent Stroke
|New England Journal of Medicine|2021|711
Use of an Intrapericardial, Continuous-Flow, Centrifugal Pump in Patients Awaiting Heart Transplantation
|Circulation|2012|655
Continuous Flow Left Ventricular Assist Device Improves Functional Capacity and Quality of Life of Advanced Heart Failure Patients
|Journal of the American College of Cardiology|2010|583